XGBoost Model With CMR Features for Prognostic Assessment in Patients With ST-Segment Elevation Myocardial Infarction

Yizhi Zhang1, Jiyuan Chen1, Zhiguo Zou1

  • 1Department of Cardiology, Shanghai Renji Hospital, School of Medicine, Shanghai Jiaotong University School of Medicine, Shanghai, China.

JACC. Asia
|July 2, 2026
PubMed

Insights

Predicting long-term adverse events after ST-segment elevation myocardial infarction (STEMI) is crucial. An XGBoost model using clinical and cardiac magnetic resonance (CMR) imaging data accurately forecasts these events, identifying microvascular obstruction as a key predictor.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Machine Learning

Background:

  • Accurate prognosis for ST-segment elevation myocardial infarction (STEMI) is vital for clinical decision-making.
  • Existing models may not fully leverage advanced imaging and machine learning techniques.

Purpose of the Study:

  • To develop predictive models for long-term major adverse cardiac and cerebrovascular events (MACCEs) in STEMI patients.
  • To integrate demographic, clinical, and cardiac magnetic resonance (CMR) imaging data for enhanced prediction.
  • To compare the performance of different machine learning algorithms in forecasting MACCEs.

Main Methods:

  • Development of four predictive models (naive Bayes, logistic regression, k-nearest neighbors, XGBoost) using 24 variables.
  • Utilized CMR imaging data acquired within 1 week and 1 month post-primary percutaneous coronary intervention.
  • Assessed model interpretability using Shapley values.

Main Results:

  • The XGBoost model exhibited superior predictive performance for long-term MACCEs.
  • Key CMR predictors included microvascular obstruction, left ventricular ejection fraction recovery, and infarct size.
  • Clinical factors like Killip class, BMI, and age also significantly influenced predictions.

Conclusions:

  • An XGBoost model integrating clinical and CMR data effectively predicts long-term MACCEs in STEMI patients.
  • Microvascular obstruction identified via CMR is a critical prognostic factor.
Abstract